CN101002765B - 压缩成型制剂 - Google Patents

压缩成型制剂 Download PDF

Info

Publication number
CN101002765B
CN101002765B CN2006101564628A CN200610156462A CN101002765B CN 101002765 B CN101002765 B CN 101002765B CN 2006101564628 A CN2006101564628 A CN 2006101564628A CN 200610156462 A CN200610156462 A CN 200610156462A CN 101002765 B CN101002765 B CN 101002765B
Authority
CN
China
Prior art keywords
weight
cysteine
ascorbic acid
crystalline cellulose
overall density
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN2006101564628A
Other languages
English (en)
Chinese (zh)
Other versions
CN101002765A (zh
Inventor
小贯洋一
冈田实
高桥章
村田操
金子哲男
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Publication of CN101002765A publication Critical patent/CN101002765A/zh
Application granted granted Critical
Publication of CN101002765B publication Critical patent/CN101002765B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN2006101564628A 2006-01-16 2006-12-31 压缩成型制剂 Active CN101002765B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2006-007331 2006-01-16
JP2006007331A JP5021210B2 (ja) 2006-01-16 2006-01-16 圧縮成型製剤
JP2006007331 2006-01-16

Publications (2)

Publication Number Publication Date
CN101002765A CN101002765A (zh) 2007-07-25
CN101002765B true CN101002765B (zh) 2011-10-12

Family

ID=38341887

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2006101564628A Active CN101002765B (zh) 2006-01-16 2006-12-31 压缩成型制剂

Country Status (4)

Country Link
JP (1) JP5021210B2 (enExample)
KR (1) KR101364561B1 (enExample)
CN (1) CN101002765B (enExample)
TW (1) TWI414287B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2011009440A (es) * 2009-03-13 2011-11-04 Toyama Chemical Co Ltd Tableta y polvo granulado que contiene 6-fluoro-3-hidroxi-2-pirazi ncarboxamida.
JP5733930B2 (ja) * 2009-09-09 2015-06-10 武田薬品工業株式会社 固形製剤
SI2946780T1 (sl) * 2013-01-15 2017-05-31 Fujifilm Corporation Tableta, ki vsebuje 5-hidroksi-1h-imidazol-4-karboksamid
JP6327237B2 (ja) * 2014-12-05 2018-05-23 大正製薬株式会社 固形組成物
JP7330716B2 (ja) * 2019-02-21 2023-08-22 アサヒグループ食品株式会社 アミノ酸又はその塩及びビタミンｃ含有組成物の変色抑制方法、並びに粉末組成物、顆粒、及び錠剤
JP6676816B1 (ja) * 2019-05-31 2020-04-08 シオノギヘルスケア株式会社 Ｌ−システイン配合ビタミンｃ高含有圧縮成形製剤
JP2023070979A (ja) * 2021-11-10 2023-05-22 トーアエイヨー株式会社 ベプリジルを含有する錠剤

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1593411A (zh) * 2004-01-15 2005-03-16 范敏华 一种祛斑药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001322927A (ja) * 2000-05-12 2001-11-20 Shin Etsu Chem Co Ltd 低置換度ヒドロキシプロピルセルロース含有固形製剤及びその製造方法
JP2002179559A (ja) * 2000-10-06 2002-06-26 Takeda Chem Ind Ltd 薄層糖衣錠およびその製造方法
JP2004026786A (ja) * 2002-05-10 2004-01-29 Takeda Chem Ind Ltd ビタミン製剤

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1593411A (zh) * 2004-01-15 2005-03-16 范敏华 一种祛斑药物组合物

Also Published As

Publication number Publication date
HK1104234A1 (en) 2008-01-11
TW200744572A (en) 2007-12-16
JP2007186470A (ja) 2007-07-26
CN101002765A (zh) 2007-07-25
JP5021210B2 (ja) 2012-09-05
TWI414287B (zh) 2013-11-11
KR101364561B1 (ko) 2014-02-18
KR20070076388A (ko) 2007-07-24

Similar Documents

Publication Publication Date Title
EP1985310A1 (en) Solid dosage forms
EP2218443A1 (en) Orally disintegrating tablet
KR20100121509A (ko) 구강 내 붕괴정
CN107913256A (zh) 一种治疗肺动脉高压的马西替坦口腔崩解片及其制备方法
TW202038917A (zh) 包含托法替尼或其藥學上可接受的鹽類的延長釋放配方及其製備方法
CN101791299A (zh) 一种枸橼酸钾缓释片的制备方法
US20030104059A1 (en) Controlled release tablets of metformin
CN101002765B (zh) 压缩成型制剂
US10864165B2 (en) Super-rapid disintegrating tablet, and method for producing same
EP3020416A1 (en) Ultrafast-disintegrating tablet and method for manufacturing same
EP3238712B1 (en) Very rapidly disintegrating tablet, and method for producing same
CN117442577B (zh) 一种坎地沙坦酯微片及制备方法和应用
WO2021254409A1 (zh) 一种复合物的药物组合物及其制备方法
CN103282051A (zh) 口腔内崩解片剂
CN114129528B (zh) 一种具有临床优势的新型枸橼酸西地那非制剂及其制备工艺与应用
CN117562900A (zh) 具有明显临床优势的阿哌沙班新制剂组合物及其制备方法
WO2006123213A1 (en) Modified release formulations of gliclazide
EP3845230B1 (en) Pharmaceutical composition for oral administration
CN115998694A (zh) 一种含有布瑞哌唑的口腔崩解片及其制备方法
JP5226732B2 (ja) 催眠用圧縮成型製剤
HK1104234B (en) Compression molded preparation
CN100356911C (zh) 催眠用压缩成型制剂
JP2004107258A (ja) 催眠用圧縮成型製剤
CN118873673A (zh) 枸橼酸莫沙必利共研磨物、其制备方法及其用途
JPH09249563A (ja) チザニジン含有組成物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1104234

Country of ref document: HK

C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1104234

Country of ref document: HK